Evercore ISI Downgrades Crinetics (CRNX) to In Line

Evercore ISI analyst Gavin Clark-Gartner downgraded Crinetics (NASDAQ: CRNX) from Outperform to In Line with a price target of $85.00 (from $88.00).

For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.

Shares of Crinetics closed at $83.53 yesterday.

You May Also Be Interested In

• Goldman Sachs Downgrades Vale S.A. (VALE) to Neutral
• WuXi XDC Cayman Inc (2268:HK) PT Lowered to HK$82.60 at Nomura/Instinet
• Hyundai Rotem Co Ltd (064350:KS) PT Lowered to KRW310,000 at Nomura/Instinet